metricas
covid
Buscar en
Medicina Clínica
Toda la web
Inicio Medicina Clínica Implicaciones del registro REACH para el endocrinólogo
Journal Information
Vol. 132. Issue S2.
Optimización de la reducción global de riesgos: implicaciones del registro REACH
Pages 21-24 (June 2009)
Share
Share
Download PDF
More article options
Vol. 132. Issue S2.
Optimización de la reducción global de riesgos: implicaciones del registro REACH
Pages 21-24 (June 2009)
Implicaciones del registro REACH para el endocrinólogo
Implications of the REACH registry for endocrinologists
Visits
11233
Guillermo Alonsoa
a Servicio de Endocrinología, Hospital Universitario San Cecilio, Granada, España
This item has received
Article information

La diabetes mellitus es un problema sanitario de enormes proporciones por su creciente incidencia poblacional y la morbimortalidad asociada a sus complicaciones micro y macrovasculares. Los pacientes diabéticos presentan un incremento de 2 a 5 veces de riesgo de enfermedad coronaria, cerebrovascular y enfermedad arterial periférica. El estudio REACH es el mayor registro mundial diseñado para obtener información pronóstica y sobre manejo terapéutico de una amplia población con riesgo de presentar episodios aterotrombóticos. Los resultados mostraron una elevada prevalencia de pacientes con obesidad, diabetes mellitus y síndrome metabólico en población de alto riesgo cardiovascular y que el grado de control de la diabetes mellitus es claramente insuficiente. Para el endocrinólogo y diabetólogo, los datos del REACH demuestran que en la prevención de enfermedades cardiovasculares es imperativo un enfoque multidisciplinario y que en el tratamiento integral del paciente diabético es imprescindible una estratificación del riesgo cardiovascular teniendo en cuenta las entidades concomitantes asociadas, como la obesidad, la hipertensión arterial, la dislipemia, la microalbuminuria y el tabaquismo.

Palabras clave:
Diabetes mellitus
Síndrome metabólico
Enfermedad cardiovascular

Diabetes mellitus is a major public health problem due to its increasing incidence in the general population and the morbidity and mortality associated with micro- and macrovascular complications. Patients with diabetes have a 2-5-fold increased risk of coronary heart disease, stroke and peripheral artery disease. The REACH registry is the largest observational study in the world designed to assess prognostic and therapeutic data in the population with elevated risk for atherothrombotic events. The results of this study show a high prevalence of obesity, diabetes mellitus and metabolic syndrome in the population with increased cardiovascular risk. Moreover, the data demonstrate that metabolic control of diabetes mellitus is clearly inadequate. Data from the REACH registry show endocrinologists and diabetologists that a multidisciplinary approach is imperative and that adequate management of diabetic patients should include stratification of cardiovascular risk, including assessment of associated conditions such as obesity, hypertension, dyslipidemia, microalbuminuria and smoking.

Keywords:
Diabetes mellitus
Metabolic syndrome
Cardiovascular disease

Article

These are the options to access the full texts of the publication Medicina Clínica
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos